U.S. Markets closed
  • S&P 500

    3,621.63
    -16.72 (-0.46%)
     
  • Dow 30

    29,638.64
    -271.73 (-0.91%)
     
  • Nasdaq

    12,198.74
    -7.11 (-0.06%)
     
  • Russell 2000

    1,819.82
    -35.45 (-1.91%)
     
  • Crude Oil

    45.23
    -0.11 (-0.24%)
     
  • Gold

    1,782.10
    +1.20 (+0.07%)
     
  • Silver

    22.74
    +0.14 (+0.63%)
     
  • EUR/USD

    1.1950
    +0.0016 (+0.1315%)
     
  • 10-Yr Bond

    0.8440
    +0.0020 (+0.24%)
     
  • Vix

    20.57
    -0.27 (-1.30%)
     
  • GBP/USD

    1.3342
    +0.0010 (+0.0787%)
     
  • USD/JPY

    104.2600
    -0.0640 (-0.0613%)
     
  • BTC-USD

    19,494.37
    -118.36 (-0.60%)
     
  • CMC Crypto 200

    382.36
    +17.76 (+4.87%)
     
  • FTSE 100

    6,266.19
    -101.39 (-1.59%)
     
  • Nikkei 225

    26,678.49
    +244.87 (+0.93%)
     

Coherus BioSciences: 3Q Earnings Snapshot

·1 min read

REDWOOD CITY, Calif. (AP) _ Coherus BioSciences Inc. (CHRS) on Thursday reported third-quarter profit of $27.9 million.

The Redwood City, California-based company said it had profit of 33 cents per share.

The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of 35 cents per share.

The drug developer posted revenue of $113.6 million in the period, also missing Street forecasts. Four analysts surveyed by Zacks expected $120.5 million.

Coherus BioSciences shares have risen 1.5% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $18.28, a climb of 12% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CHRS at https://www.zacks.com/ap/CHRS